Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bluebird bio Inc (NASDAQ: BLUE) closed the day trading at $0.47 down -9.39% from the previous closing price of $0.52. In other words, the price has decreased by -$9.39 from its previous closing price. On the day, 7.52 million shares were traded. BLUE stock price reached its highest trading level at $0.5189 during the session, while it also had its lowest trading level at $0.4695.
Ratios:
For a better understanding of BLUE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.68. In the meantime, Its Debt-to-Equity ratio is 7.37 whereas as Long-Term Debt/Eq ratio is at 3.67.
Morgan Stanley Upgraded its Underweight to Equal-Weight on December 08, 2023, whereas the target price for the stock was revised from $3 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 30 ’24 when Obenshain Andrew bought 34,780 shares for $0.52 per share.
Klima Thomas J bought 1,006 shares of BLUE for $523 on Sep 30 ’24. On Jun 03 ’24, another insider, Klima Thomas J, who serves as the insider of the company, sold 3,834 shares for $0.97 each. As a result, the insider received 3,726 and left with 121,006 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 91275320 and an Enterprise Value of 342848128. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.66 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 6.245 whereas that against EBITDA is -1.135.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -38.14%, while the 200-Day Moving Average is calculated to be -57.05%.
Shares Statistics:
Over the past 3-months, BLUE traded about 7.36M shares per day on average, while over the past 10 days, BLUE traded about 7875580 shares per day. A total of 193.91M shares are outstanding, with a floating share count of 193.05M. Insiders hold about 0.44% of the company’s shares, while institutions hold 42.41% stake in the company. Shares short for BLUE as of 1726185600 were 48403895 with a Short Ratio of 6.58, compared to 1723680000 on 41140699. Therefore, it implies a Short% of Shares Outstanding of 48403895 and a Short% of Float of 26.639998.
